Chemoinformaics analysis of Dihydroisoconessimine
| Molecular Weight | 344.587 | nRot | 1 |
| Heavy Atom Molecular Weight | 304.267 | nRig | 24 |
| Exact Molecular Weight | 344.319 | nRing | 5 |
| Solubility: LogS | -4.093 | nHRing | 1 |
| Solubility: LogP | 4.128 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 67.2817 |
| nHD | 1 | BPOL | 42.4083 |
| QED | 0.751 |
| Synth | 4.938 |
| Natural Product Likeliness | 2.535 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.024 |
| CACO-2 | -4.837 |
| MDCK | 0.0000052 |
| BBB | 0.207 |
| PPB | 0.571054 |
| VDSS | 1.262 |
| FU | 0.368117 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.535 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.982 |
| CYP2c9-inh | 0.064 |
| CYP2c9-sub | 0.05 |
| CYP2d6-inh | 0.818 |
| CYP2d6-sub | 0.932 |
| CYP3a4-inh | 0.104 |
| CYP3a4-sub | 0.763 |
| CL | 19.399 |
| T12 | 0.046 |
| hERG | 0.148 |
| Ames | 0.015 |
| ROA | 0.201 |
| SkinSen | 0.685 |
| Carcinogencity | 0.027 |
| EI | 0.006 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.001 |
| Antiviral | No |
| Prediction | 0.685409 |